Literature DB >> 8454846

Human T cell lines and clones respond to IL-9.

F A Houssiau1, J C Renauld, M Stevens, F Lehmann, B Lethe, P G Coulie, J Van Snick.   

Abstract

The activity of IL-9 on human T cells was investigated. Human T cell lines and clones, derived from PBMC by stimulation with PHA, IL-2, and irradiated allogeneic PBMC, were found to express a strong IL-9R message at the RNA level and to proliferate in the presence of IL-9, irrespectively of their CD4+ or CD8+ phenotype. Moreover, tumor-specific CTL clones also responded to IL-9. Contrasting with other T cell growth factors, such as IL-2, IL-4, or IL-7, IL-9 did not induce the proliferation of freshly isolated T cells. However, a significant proliferative response to IL-9 could be observed after a 10-day activation of PBMC with PHA, IL-2, and feeders. Taken together, our results indicate 1) that the activity of IL-9 on human T cells is wider than initially anticipated on the basis of the data obtained so far with murine cells; and 2) that proliferative responses to IL-9 require previous activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8454846

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  IL-9 promotes anti-Mycobacterium leprae cytotoxicity: involvement of IFNgamma.

Authors:  M R Finiasz; M C Franco; S de la Barrera; L Rutitzky; G Pizzariello; M del Carmen Sasiain; J-C Renauld; J Van Snick; S Fink
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

Review 3.  IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity.

Authors:  Hongmei Li; Abdolmohamad Rostami
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-18       Impact factor: 4.147

4.  Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells.

Authors:  Lin Qiu; Raymond Lai; Quan Lin; Esther Lau; David M Thomazy; Daniel Calame; Richard J Ford; Larry W Kwak; Robert A Kirken; Hesham M Amin
Journal:  Blood       Date:  2006-06-08       Impact factor: 22.113

5.  A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9.

Authors:  J B Demoulin; C Uyttenhove; E Van Roost; B DeLestré; D Donckers; J Van Snick; J C Renauld
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

Review 6.  Regulation of allergic airways inflammation by cytokines and glucocorticoids.

Authors:  L Cameron; Q Hamid
Journal:  Curr Allergy Asthma Rep       Date:  2001-03       Impact factor: 4.806

7.  Potentiating adoptive cell therapy using synthetic IL-9 receptors.

Authors:  Anusha Kalbasi; Mikko Siurala; Leon L Su; Mito Tariveranmoshabad; Lora K Picton; Pranali Ravikumar; Peng Li; Jian-Xin Lin; Helena Escuin-Ordinas; Tong Da; Sarah V Kremer; Amy L Sun; Sofia Castelli; Sangya Agarwal; John Scholler; Decheng Song; Philipp C Rommel; Enrico Radaelli; Regina M Young; Warren J Leonard; Antoni Ribas; Carl H June; K Christopher Garcia
Journal:  Nature       Date:  2022-06-08       Impact factor: 69.504

8.  Interleukin-7 activates intestinal lymphocytes.

Authors:  M Bilenker; A I Roberts; R E Brolin; E C Ebert
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

9.  TGF-beta induces IL-9 production from human Th17 cells.

Authors:  Gaëlle Beriou; Elizabeth M Bradshaw; Ester Lozano; Cristina M Costantino; William D Hastings; Tihamer Orban; Wassim Elyaman; Samia J Khoury; Vijay K Kuchroo; Clare Baecher-Allan; David A Hafler
Journal:  J Immunol       Date:  2010-05-24       Impact factor: 5.422

10.  Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness.

Authors:  U A Temann; G P Geba; J A Rankin; R A Flavell
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.